Use of Faricimab in the real-world clinical practice for non-treatment naive neovascular age-related macular degeneration patients

被引：0
|
作者：
Tran, Donald [1 ]
Trung M. Dang [1 ]
Moodie, Jonathan [1 ]
Luckie, Alan [1 ]
机构：
[1] Eye Clin Albury Wodonga, Albury, NSW, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2023年 / 51卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1020 / 1020
页数：1
相关论文
共 50 条
  • [21] Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration
    Pandit, Saagar A.
    Momenaei, Bita
    Wakabayashi, Taku
    Mansour, Hana A.
    Vemula, Sudheshna
    Durrani, Asad F.
    Pashaee, Bahram
    Kazan, Adina S.
    Ho, Allen C.
    Klufas, Michael
    Regillo, Carl
    Yonekawa, Yoshihiro
    Hsu, Jason
    Kuriyan, Ajay
    Chiang, Allen
    OPHTHALMOLOGY RETINA, 2024, 8 (04): : 360 - 366
  • [22] The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results
    Arshad M. Khanani
    Aamir A. Aziz
    Hannah Khan
    Ashwin Gupta
    Ohidul Mojumder
    Aigerim Saulebayeva
    Ashkan M. Abbey
    David R. P. Almeida
    Robert L. Avery
    Himanshu K. Banda
    Mark R. Barakat
    Ramanath Bhandari
    Emmanuel Y. Chang
    Sara J. Haug
    Nikolas J. S. London
    Luke Mein
    Veeral S. Sheth
    Jeremy D. Wolfe
    Michael A. Singer
    Carl J. Danzig
    Eye, 2023, 37 : 3574 - 3581
  • [23] One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
    Cancian, Giuseppe
    Paris, Arianna
    Agliati, Lia
    Rizzato, Angelica
    Clerici, Michele
    Volpe, Giulio
    Menghini, Moreno
    Grimaldi, Gabriela
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (11) : 2985 - 2997
  • [24] Real-World-Data of Treatment-Naive and Previously Treated Patients Receiving Up to 3 Injections of Faricimab in Neovascular Age-Related Macular Degeneration
    Kunzmann, Berenike Cornelia
    Schweig, Alexandra Stefanie
    Bartz-Schmidt, Karl Ulrich
    Sobolewska, Bianka
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 4029 - 4039
  • [25] Real-world outcomes for fellow eyes in neovascular age-related macular degeneration
    Aydogmus, Fatma Sema Akkan
    Onwuka, Oluchukwu
    Saddemi, Jackson
    Lasalle, Claudia
    Ramsey, David J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [26] Real-world evidence for neovascular age-related macular degeneration: a practical approach
    Teo, Kelvin Yi Chong
    EYE, 2023, 37 (01) : 1 - 3
  • [27] Real-world evidence for neovascular age-related macular degeneration: a practical approach
    Kelvin Yi Chong Teo
    Eye, 2023, 37 : 1 - 3
  • [28] Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence
    Daien, Vincent
    Finger, Robert P.
    Talks, James S.
    Mitchell, Paul
    Wong, Tien Y.
    Sakamoto, Taiji
    Eldem, Bora M.
    Korobelnik, Jean-Francois
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (11) : 1475 - 1479
  • [29] METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Kim, Leah N.
    Mehta, Hemal
    Barthelmes, Daniel
    Vuong Nguyen
    Gillies, Mark C.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (08): : 1418 - 1431
  • [30] REAL WORLD EFFICACY AND DURABILITY OF FARICIMAB IN SUB-OPTIMAL RESPONDER PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Hernaez, Jimena Soto
    Goodchild, Christine
    Bailey, Clare
    Ahmed, Eslam
    Salvatore, Serena
    EYE, 2024, 38 : 162 - 163
12345